Speech-Language Pathologists in Breinigsville, PA Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Mrs. Tammy Krystal Silinskie, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8657 Ash Lane, Breinigsville, PA 18031 Phone: 570-407-2723 |
Tamara Williams Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8877 Colebrook Rd, Breinigsville, PA 18031 Phone: 610-203-7226 |
Kelly Ann Markowitz, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8583 Pathfinder Rd, Breinigsville, PA 18031 Phone: 484-221-8029 |
Mrs. Nicole Stevens, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1564 Silo Hill Ln, Breinigsville, PA 18031 Phone: 484-269-1469 |
News Archive
Favorable initial results from Novavax' 2009 H1N1 VLP pandemic influenza vaccine Phase II study
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
Mild COVID-19 disease may trigger long-term immunity
Researchers in the United States have conducted a study showing that individuals who have recovered from mild coronavirus disease 2019 (COVID-19) developed sustained protective immune memory against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Reducing albuterol use in children with bronchiolitis without compromising care
Bronchiolitis, a lung infection that is one of the most common reasons for hospitalizations in young children, is most prevalent during the winter months and is usually treated with albuterol delivered via inhalers, despite evidence showing no benefit in most patients.
Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.
Research sheds light on the underprediction riddle of biomass burning
Oxidized organic aerosol is a major component of ambient particulate matter, substantially impacting climate, human health, and ecosystems.
› Verified 3 days ago
Chiropractors
Speech-Language Pathologists
Physical Therapists